The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences
Top Cited Papers
Open Access
- 8 September 2017
- journal article
- research article
- Published by Wiley in Clinical and Translational Science
- Vol. 11 (1) , 77-84
Abstract
We report the development of the Translational Science Benefits Model (TSBM), a framework designed to support institutional assessment of clinical and translational research outcomes to measure clinical and community health impacts beyond bibliometric measures. The TSBM includes 30 specific and potentially measurable indicators that reflect benefits that accrue from clinical and translational science research such as products, system characteristics, or activities. Development of the TSBM was based on literature review, a modified Delphi method, and in‐house expert panel feedback. Three case studies illustrate the feasibility and face validity of the TSBM for identification of clinical and community health impacts that result from translational science activities. Future plans for the TSBM include further pilot testing and a resource library that will be freely available for evaluators, translational scientists, and academic institutions who wish to implement the TSBM framework in their own evaluation efforts.Keywords
Funding Information
- National Center for Advancing Translational Sciences
- National Institutes of Health
This publication has 30 references indexed in Scilit:
- The Specificity of Urinary Aquaporin 1 and Perilipin 2 to Screen for Renal Cell CarcinomaJournal of Urology, 2013
- National Institutes of Health Approaches to Dissemination and Implementation Science: Current and Future DirectionsAmerican Journal of Public Health, 2012
- ‘Impact’ in the proposals for the UK's Research Excellence Framework: Shifting the boundaries of academic autonomyResearch Policy, 2011
- State of the art in assessing research impact: introduction to a special issueResearch Evaluation, 2011
- Practice Bulletin No. 121: Long-Acting Reversible Contraception: Implants and Intrauterine DevicesObstetrics & Gynecology, 2011
- Evaluating Translational Research: A Process Marker ModelClinical and Translational Science, 2011
- Beyond citation analysis: a model for assessment of research impactJournal of the Medical Library Association, 2010
- The Meaning of Translational Research and Why It MattersJAMA, 2008
- The program logic model as an integrative framework for a multimethod evaluationEvaluation and Program Planning, 2001
- An experimental study of group opinionFutures, 1969